Match!

RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular Carcinoma: Propensity Score Analyses of Mid-Term Outcomes

Published on Mar 1, 2020in CardioVascular and Interventional Radiology1.928
· DOI :10.1007/S00270-019-02394-4
So Yeon Cha1
Estimated H-index: 1
(SMC: Samsung Medical Center),
Tae Wook Kang20
Estimated H-index: 20
(SMC: Samsung Medical Center)
+ 6 AuthorsMin Su Park1
Estimated H-index: 1
(SMC: Samsung Medical Center)
Abstract
Purpose This study aimed to compare radiofrequency (RF) ablation with cryoablation in patients with perivascular hepatocellular carcinoma (HCC) and evaluate the mid-term outcomes of both therapies.
  • References (29)
  • Citations (2)
📖 Papers frequently viewed together
15 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References29
Newest
#1Ran Kim (SKKU: Sungkyunkwan University)H-Index: 1
#2Tae Wook Kang (SKKU: Sungkyunkwan University)H-Index: 20
Last. Dong Hyun Sinn (SKKU: Sungkyunkwan University)H-Index: 23
view all 8 authors...
Objectives To evaluate the therapeutic efficacy of and vascular complications associated with percutaneous cryoablation for the treatment of perivascular HCC.
1 CitationsSource
#1Dong Hyun Sinn (SMC: Samsung Medical Center)H-Index: 23
#2Gyu-Seong Choi (SMC: Samsung Medical Center)H-Index: 8
Last. Seung Woon Paik (SMC: Samsung Medical Center)H-Index: 40
view all 29 authors...
Background Given the complexity of managing hepatocellular carcinoma (HCC), a multidisciplinary approach (MDT) is recommended to optimize management of HCC patients. However, evidence suggesting that MDT improves patient outcome is limited. Methods We performed a retrospective cohort study of all patients newly-diagnosed with HCC between 2005 and 2013 (n = 6,619). The overall survival (OS) rates between the patients who were and were not managed via MDT were compared in the entire cohort (n = 6,...
4 CitationsSource
#1Tae Wook KangH-Index: 20
#2Hyo Keun LimH-Index: 1
Last. Dong Ik ChaH-Index: 13
view all 3 authors...
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
5 CitationsSource
#1Sun-Young Lee (SMC: Samsung Medical Center)H-Index: 42
#2Tae Wook Kang (SMC: Samsung Medical Center)H-Index: 20
Last. Kyunga Kim (SMC: Samsung Medical Center)H-Index: 11
view all 10 authors...
Background & Aims The therapeutic outcomes of surgical resection (SR) or radiofrequency ablation (RFA) for perivascular hepatocellular carcinoma (HCC) have not been compared. The aim of this study was to compare SR with RFA as first-line treatment in patients with perivascular HCC and to evaluate the long-term outcomes of both therapies. Methods This retrospective study was approved by the institutional review board. The requirement for informed consent was waived. Between January 2006 and Decem...
8 CitationsSource
#1Peter R. GalleH-Index: 91
#2Alejandro Forner (European Organisation for Research and Treatment of Cancer)H-Index: 30
Last. Valérie VilgrainH-Index: 75
view all 8 authors...
Summary Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
1,896 CitationsSource
#1Kyoung Doo SongH-Index: 15
#2Min Woo LeeH-Index: 30
Last. Hyo Keun LimH-Index: 53
view all 7 authors...
Percutaneous US/MRI fusion–guided radiofrequency ablation was feasible in approximately two-thirds of subcentimeter recurrent hepatocellular carcinomas and was an effective and safe treatment modality in those selected patients.
4 CitationsSource
#1Jean-Charles Nault (French Institute of Health and Medical Research)H-Index: 31
#2Olivier SutterH-Index: 4
Last. Olivier Seror (French Institute of Health and Medical Research)H-Index: 23
view all 5 authors...
Summary Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA, microwave ablation, cryoablation and irreversible electroporation. RFA is considered one of the main curative treatments for HCC of less than 5 cm developing on cirrhotic liver, together with surgical resection and liver transplantation. However, controversies exist concerning the respective roles of ablation and liver resec...
33 CitationsSource
#1Dimitris Filippiadis (UoA: National and Kapodistrian University of Athens)H-Index: 5
#2Christoph A. Binkert (Winterthur Museum, Garden and Library)H-Index: 22
Last. Philippe L. Pereira (Heidelberg University)H-Index: 35
view all 6 authors...
Interventional radiology provides a wide variety of vascular, nonvascular, musculoskeletal, and oncologic minimally invasive techniques aimed at therapy or palliation of a broad spectrum of pathologic conditions. Outcome data for these techniques are globally evaluated by hospitals, insurance companies, and government agencies targeting in a high-quality health care policy, including reimbursement strategies. To analyze effectively the outcome of a technique, accurate reporting of complications ...
83 CitationsSource
#1Tae Wook KangH-Index: 20
#2Hyo Keun LimH-Index: 53
Last. Dong Ik Cha (SMC: Samsung Medical Center)H-Index: 13
view all 3 authors...
Image-guided radiofrequency ablation (RFA) is an evolving and growing treatment option for patients with hepatocellular carcinoma (HCC) and hepatic metastasis. RFA offers significant advantages as it is less invasive than surgery and carries a low risk of major complications. However, serious complications, including aggressive tumor recurrence, may be observed during follow-up, and recently, mechanical or thermal damage during RFA has been proposed to be one of the causes of this kind of recurr...
6 CitationsSource
#1Deok Hee LeeH-Index: 52
#2Jeong Min LeeH-Index: 61
Last. Joon Koo HanH-Index: 63
view all 5 authors...
The development of radiofrequency ablation (RFA)–induced hepatic parenchymal hypoperfusion after RFA of a single nodular hepatocellular carcinoma is associated with an increased risk of recurrence; therefore, it is of critical importance to minimize thermal injury–induced vascular damage during RFA.
8 CitationsSource
Cited By2
Newest
Objective To investigate the clinical safety, efficacy, therapeutic outcomes and risk factors of computed tomography-guided percutaneous cryoablation (CT-PCRA) for subcardiac hepatocellular carcinoma (HCC). Patients and Methods In this study, patients with single HCC nodules located on the left lobe who subsequently underwent CT-PCRA were reviewed from July 2012 to August 2016. According to the definition of subcardiac HCC, the patients were grouped into the subcardiac HCC group (n=33) and the n...
Source
#1Alban DenysH-Index: 43
#2Boris GuiuH-Index: 30
Last. Thierry de BaereH-Index: 51
view all 6 authors...
The COVID-19 pandemic has deeply impacted the activity of interventional oncology in hospitals and cancer centers. In this review based on official recommendations of different international societies, but also on local solutions found in different expert large-volume centers, we discuss the changes that need to be done for the organization, safety, and patient management in interventional oncology. A literature review of potential solutions in a context of scarce anesthesiologic resources, limi...
3 CitationsSource